ATE294239T1 - Streptokinasemutanten - Google Patents

Streptokinasemutanten

Info

Publication number
ATE294239T1
ATE294239T1 AT99202639T AT99202639T ATE294239T1 AT E294239 T1 ATE294239 T1 AT E294239T1 AT 99202639 T AT99202639 T AT 99202639T AT 99202639 T AT99202639 T AT 99202639T AT E294239 T1 ATE294239 T1 AT E294239T1
Authority
AT
Austria
Prior art keywords
streptokinase
mutants
present
skc
obtaining
Prior art date
Application number
AT99202639T
Other languages
English (en)
Inventor
Madrazo Isis Del Carme Torrens
Ojalvo Ariana Garcia
La Fuente Garcia Jose De Je De
Menendez Alina Seralena
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE294239T1 publication Critical patent/ATE294239T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT99202639T 1998-08-14 1999-08-13 Streptokinasemutanten ATE294239T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1998119A CU22732A1 (es) 1998-08-14 1998-08-14 Mutantes de estreptoquinasa

Publications (1)

Publication Number Publication Date
ATE294239T1 true ATE294239T1 (de) 2005-05-15

Family

ID=5459400

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99202639T ATE294239T1 (de) 1998-08-14 1999-08-13 Streptokinasemutanten

Country Status (7)

Country Link
US (2) US6309873B1 (de)
EP (1) EP0985729B1 (de)
AT (1) ATE294239T1 (de)
AU (1) AU769916B2 (de)
CA (1) CA2277554C (de)
CU (1) CU22732A1 (de)
DE (1) DE69924932D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750329B1 (en) * 1989-05-05 2004-06-15 Research Development Foundation Antibody delivery system for biological response modifiers
US6348567B1 (en) * 1995-12-06 2002-02-19 Cv Molecular Therapeutics Inc. Peptides and their use to ameliorate cell death
ZA200305980B (en) * 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
WO2003007889A2 (en) * 2001-07-17 2003-01-30 Research Development Foundation Therapeutic agents comprising pro-apoptotic proteins
WO2003105761A2 (en) * 2002-06-12 2003-12-24 Research Development Foundation Immunotoxin as a therapeutic agent and uses thereof
WO2009149199A2 (en) * 2008-06-04 2009-12-10 Talecris Biotherapeutics, Inc. Composition, method and kit for preparing plasmin
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2238180A (en) * 1989-11-14 1991-05-22 Stc Plc Cable laying equipment
CU22277A1 (es) * 1990-05-23 1995-01-31 Cigb Procedimiento para el aislamiento y expresion de un gen codificante para estreptoquinasa,secuencia nucleotidica obtenida,adn recombinantes y microorganismos transformados
US5854049A (en) * 1995-06-09 1998-12-29 President And Fellows Of Harvard College Plasmin-resistant streptokinase

Also Published As

Publication number Publication date
US6413759B1 (en) 2002-07-02
EP0985729A2 (de) 2000-03-15
CA2277554C (en) 2004-11-02
US6309873B1 (en) 2001-10-30
EP0985729A3 (de) 2000-05-31
AU769916B2 (en) 2004-02-12
EP0985729B1 (de) 2005-04-27
DE69924932D1 (de) 2005-06-02
CA2277554A1 (en) 2000-02-14
CU22732A1 (es) 2002-02-28
AU4342499A (en) 2000-03-09

Similar Documents

Publication Publication Date Title
ATE294239T1 (de) Streptokinasemutanten
ATE292180T1 (de) Fibrinolytisch wirksames polypeptid
DE69943393D1 (de) Ein plasmaprotein-fragment erzeugendes enzym mit krebsmetastase-hemmender wirkung und durch dieses enzym fragmentiertes plasmaprotein-fragment
DE10199042I1 (de) Protein mit Urate-Oxidase-Aktivitaet dafuer kodierendes rekombinantes Gen Expressionsvektor Mikroorganismen und Transformanten
DE69021885D1 (de) Mutanten des menschlichen plasminogenaktivator-inhibitors 1 (pai-1), ihre herstellung und verwendung.
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
ATE93273T1 (de) Neue fibrinolytische enzyme.
ATE194624T1 (de) Mutanten von menschlichem antithrombin iii
Sasmita et al. Purification and characterization of a fibrinolytic enzyme from tempeh bongkrek as an alternative of thrombolytic agents
JP2001505765A (ja) 組織型プラスミノーゲンアクチベーター（ｔ―ＰＡ）の変異体：組成物およびその使用方法
DE3853479D1 (de) Ausgeglichenes, konstitutives, induzierbares transkriptionssystem.
US6706504B1 (en) Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
DK0517756T3 (da) Vævs-plasminogenaktivator med fibrinspecifikke egenskaber
Sui et al. Stability of plasminogen activator inhibitor-1: role of tyrosine221
Hamelin et al. Implication of cystein residues in the activity of single-chain urokinase-plasminogen activator
Buniya et al. Optimized Expression and Activity Assessment of Bacterial Staphylokinase in E. coli BL21 (DE3)
Takagi et al. Enhanced thermostability of the single-Cys mutant subtilisin E under oxidizing conditions
Lu et al. Expression of human plasminogen kringle 5 as fusion protein with truncated hIFNγ gene in Escherichia coli
Miyake et al. Synthesis of recombinant human single-chain urokinase-type plasminogen activator variants resistant to plasmin and thrombin
EA200300502A1 (ru) СПОСОБЫ КРУПНОМАСШТАБНОГО ПРОИЗВОДСТВА ВЫВЕДЕННЫХ ИЗ РЕКОМБИНАНТНОЙ ДНК МОЛЕКУЛ tPA ИЛИ K2S
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
MXPA00011249A (es) Complejo de enzima de citocromo c oxidasa.
Kubo et al. Improved method for pro-urokinase refolding with inclusion body from recombinant Escherichia coli
Tuan et al. Purification and thrombolytic effects in vivo of recombination Nattokinase on carrageenan-induced tail thrombosis in a rat model
Kim et al. Genetic organization of the recombinant Bacillus pasteurii urease genes expressed in Escherichia coli

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties